Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ethics, Medical | 13 | 2023 | 785 | 1.570 |
Why?
|
Conflict of Interest | 8 | 2015 | 556 | 1.480 |
Why?
|
Thoracic Surgery | 13 | 2014 | 727 | 1.230 |
Why?
|
Truth Disclosure | 4 | 2015 | 433 | 0.930 |
Why?
|
Ethics, Clinical | 5 | 2010 | 101 | 0.870 |
Why?
|
Informed Consent | 8 | 2015 | 1012 | 0.850 |
Why?
|
Bioethics | 4 | 2010 | 118 | 0.600 |
Why?
|
Withholding Treatment | 3 | 2007 | 621 | 0.550 |
Why?
|
General Surgery | 6 | 2013 | 1714 | 0.520 |
Why?
|
Authorship | 2 | 2011 | 287 | 0.510 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2015 | 4049 | 0.470 |
Why?
|
Diffusion of Innovation | 3 | 2011 | 730 | 0.470 |
Why?
|
Trust | 4 | 2017 | 532 | 0.470 |
Why?
|
Publishing | 5 | 2011 | 836 | 0.450 |
Why?
|
Ethics Committees, Research | 2 | 2003 | 196 | 0.390 |
Why?
|
Life Support Care | 2 | 2017 | 226 | 0.380 |
Why?
|
Internship and Residency | 9 | 2019 | 5952 | 0.360 |
Why?
|
Canada | 9 | 2015 | 2143 | 0.350 |
Why?
|
Patient Advocacy | 4 | 2007 | 362 | 0.350 |
Why?
|
Thoracoscopy | 3 | 1998 | 186 | 0.350 |
Why?
|
Therapies, Investigational | 1 | 2011 | 111 | 0.350 |
Why?
|
Policy Making | 1 | 2014 | 545 | 0.340 |
Why?
|
Euthanasia | 2 | 2007 | 58 | 0.340 |
Why?
|
Thoracic Surgical Procedures | 2 | 2011 | 350 | 0.340 |
Why?
|
Health Care Sector | 1 | 2011 | 196 | 0.330 |
Why?
|
Research Support as Topic | 5 | 2011 | 699 | 0.300 |
Why?
|
Religion and Medicine | 3 | 2007 | 161 | 0.300 |
Why?
|
Industry | 3 | 2013 | 366 | 0.300 |
Why?
|
Professional Autonomy | 1 | 2009 | 172 | 0.300 |
Why?
|
Attitude of Health Personnel | 5 | 2015 | 3922 | 0.280 |
Why?
|
Decision Making | 6 | 2015 | 3961 | 0.280 |
Why?
|
Accidents, Occupational | 1 | 2008 | 252 | 0.280 |
Why?
|
BCG Vaccine | 12 | 1988 | 383 | 0.280 |
Why?
|
Editorial Policies | 1 | 2011 | 459 | 0.270 |
Why?
|
Curriculum | 4 | 2023 | 3778 | 0.270 |
Why?
|
Lung Neoplasms | 28 | 1996 | 13589 | 0.270 |
Why?
|
Myoblasts, Cardiac | 1 | 2006 | 21 | 0.270 |
Why?
|
Patient Acceptance of Health Care | 4 | 2017 | 3237 | 0.270 |
Why?
|
Cloning, Organism | 1 | 2006 | 50 | 0.260 |
Why?
|
Specialties, Surgical | 3 | 2015 | 393 | 0.260 |
Why?
|
Patients | 1 | 2013 | 909 | 0.260 |
Why?
|
Embryo Research | 1 | 2006 | 38 | 0.260 |
Why?
|
Medical Futility | 1 | 2007 | 136 | 0.260 |
Why?
|
Ethics | 2 | 2002 | 94 | 0.250 |
Why?
|
Drug Industry | 1 | 2011 | 793 | 0.240 |
Why?
|
Cardiology | 3 | 2007 | 1701 | 0.240 |
Why?
|
Professional-Family Relations | 2 | 2014 | 501 | 0.240 |
Why?
|
Palliative Care | 3 | 2017 | 3644 | 0.230 |
Why?
|
Publications | 1 | 2007 | 196 | 0.230 |
Why?
|
Pneumonectomy | 7 | 1994 | 1159 | 0.230 |
Why?
|
Education, Medical, Graduate | 6 | 2010 | 2411 | 0.220 |
Why?
|
Patient Rights | 2 | 2014 | 127 | 0.220 |
Why?
|
Advance Directives | 2 | 2017 | 249 | 0.220 |
Why?
|
Therapeutic Human Experimentation | 1 | 2003 | 43 | 0.220 |
Why?
|
Aortic Aneurysm | 1 | 2008 | 649 | 0.210 |
Why?
|
Carcinoid Tumor | 2 | 1996 | 226 | 0.210 |
Why?
|
Jehovah's Witnesses | 1 | 2002 | 13 | 0.210 |
Why?
|
Physician-Patient Relations | 6 | 2017 | 3267 | 0.210 |
Why?
|
Cholelithiasis | 1 | 2004 | 408 | 0.210 |
Why?
|
Clinical Competence | 3 | 2011 | 4841 | 0.200 |
Why?
|
Societies, Medical | 2 | 2014 | 3955 | 0.200 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2004 | 236 | 0.200 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2013 | 1418 | 0.200 |
Why?
|
Thymus Neoplasms | 2 | 1996 | 278 | 0.200 |
Why?
|
Ethics, Research | 1 | 2003 | 177 | 0.200 |
Why?
|
Intraoperative Complications | 1 | 2009 | 1176 | 0.200 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2013 | 1401 | 0.200 |
Why?
|
Education, Medical | 1 | 2014 | 1742 | 0.190 |
Why?
|
Surgical Procedures, Operative | 3 | 2015 | 1937 | 0.180 |
Why?
|
Physicians | 4 | 2013 | 4615 | 0.180 |
Why?
|
Refusal to Treat | 1 | 2001 | 42 | 0.180 |
Why?
|
Evidence-Based Medicine | 2 | 2011 | 3708 | 0.180 |
Why?
|
Blood Transfusion | 2 | 2002 | 1308 | 0.180 |
Why?
|
Postoperative Complications | 8 | 2017 | 15880 | 0.180 |
Why?
|
Bronchial Neoplasms | 3 | 1996 | 111 | 0.170 |
Why?
|
Technology Assessment, Biomedical | 2 | 1996 | 308 | 0.170 |
Why?
|
Prisoners | 1 | 2003 | 317 | 0.160 |
Why?
|
Thoracic Duct | 2 | 1998 | 71 | 0.160 |
Why?
|
Humans | 88 | 2024 | 768451 | 0.160 |
Why?
|
Endoscopy | 2 | 1999 | 1857 | 0.160 |
Why?
|
Chyle | 1 | 1998 | 19 | 0.150 |
Why?
|
Health Care Rationing | 2 | 2003 | 436 | 0.150 |
Why?
|
Organ Transplantation | 1 | 2008 | 1177 | 0.150 |
Why?
|
Video Recording | 2 | 1995 | 974 | 0.150 |
Why?
|
Surgical Equipment | 2 | 2015 | 57 | 0.150 |
Why?
|
Foundations | 1 | 1998 | 96 | 0.150 |
Why?
|
Fistula | 2 | 1998 | 213 | 0.150 |
Why?
|
Stem Cell Transplantation | 1 | 2006 | 1602 | 0.140 |
Why?
|
Postoperative Care | 3 | 2017 | 1481 | 0.140 |
Why?
|
Neck Dissection | 1 | 1998 | 201 | 0.140 |
Why?
|
Esophagectomy | 1 | 2000 | 482 | 0.130 |
Why?
|
Tumor Stem Cell Assay | 2 | 1986 | 116 | 0.130 |
Why?
|
Morals | 1 | 2019 | 289 | 0.130 |
Why?
|
Physician's Role | 2 | 2007 | 927 | 0.130 |
Why?
|
Colony-Forming Units Assay | 2 | 1986 | 352 | 0.130 |
Why?
|
Treatment Refusal | 2 | 2013 | 432 | 0.130 |
Why?
|
Interviews as Topic | 4 | 2017 | 2733 | 0.130 |
Why?
|
Collagenases | 1 | 1996 | 221 | 0.130 |
Why?
|
Education, Medical, Continuing | 1 | 2001 | 829 | 0.130 |
Why?
|
Phenytoin | 1 | 1996 | 190 | 0.130 |
Why?
|
Terminal Care | 1 | 2007 | 1773 | 0.120 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2001 | 843 | 0.120 |
Why?
|
Surgical Wound Dehiscence | 1 | 1996 | 216 | 0.120 |
Why?
|
Thoracotomy | 2 | 1996 | 375 | 0.120 |
Why?
|
Advance Directive Adherence | 1 | 2014 | 19 | 0.120 |
Why?
|
Disclosure | 2 | 2013 | 750 | 0.110 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2001 | 709 | 0.110 |
Why?
|
Stomach Neoplasms | 2 | 2014 | 1484 | 0.110 |
Why?
|
Empyema | 3 | 1982 | 41 | 0.110 |
Why?
|
Ethics Consultation | 1 | 2013 | 59 | 0.110 |
Why?
|
Carcinoma, Small Cell | 5 | 1987 | 420 | 0.110 |
Why?
|
Heart Diseases | 1 | 2006 | 2816 | 0.110 |
Why?
|
Thoracoscopes | 1 | 1992 | 3 | 0.100 |
Why?
|
Pneumothorax | 1 | 1996 | 393 | 0.100 |
Why?
|
Protease Inhibitors | 1 | 1996 | 753 | 0.100 |
Why?
|
Computer Terminals | 1 | 1992 | 41 | 0.100 |
Why?
|
Adenocarcinoma | 5 | 2014 | 6400 | 0.100 |
Why?
|
Clinical Trials as Topic | 8 | 2003 | 8051 | 0.100 |
Why?
|
Aged, 80 and over | 8 | 2017 | 59680 | 0.090 |
Why?
|
Financial Management | 1 | 2013 | 161 | 0.090 |
Why?
|
Carotenoids | 1 | 1994 | 621 | 0.090 |
Why?
|
Organizational Innovation | 2 | 2003 | 540 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2000 | 1676 | 0.090 |
Why?
|
History, 20th Century | 2 | 2014 | 2772 | 0.080 |
Why?
|
Heart Transplantation | 1 | 2003 | 3291 | 0.080 |
Why?
|
Beneficence | 1 | 2009 | 56 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2002 | 3629 | 0.080 |
Why?
|
United States | 10 | 2014 | 73121 | 0.080 |
Why?
|
Rhinoplasty | 1 | 2012 | 239 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2001 | 3839 | 0.080 |
Why?
|
Ribs | 1 | 1990 | 261 | 0.080 |
Why?
|
Lipid A | 1 | 1988 | 70 | 0.070 |
Why?
|
Ontario | 3 | 2017 | 403 | 0.070 |
Why?
|
Euthanasia, Active | 1 | 2007 | 16 | 0.070 |
Why?
|
Qualitative Research | 2 | 2017 | 3115 | 0.070 |
Why?
|
Biomedical Research | 1 | 2003 | 3463 | 0.070 |
Why?
|
Euthanasia, Passive | 1 | 2007 | 64 | 0.070 |
Why?
|
Cytotoxins | 1 | 1988 | 154 | 0.070 |
Why?
|
Cholecystectomy | 1 | 2009 | 409 | 0.070 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2008 | 193 | 0.070 |
Why?
|
Faculty, Medical | 2 | 2012 | 1218 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3438 | 0.070 |
Why?
|
Totipotent Stem Cells | 1 | 2006 | 16 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 1994 | 5426 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 5 | 1998 | 4083 | 0.070 |
Why?
|
Bioethical Issues | 1 | 2007 | 120 | 0.070 |
Why?
|
Plants, Medicinal | 1 | 1986 | 167 | 0.070 |
Why?
|
Male | 30 | 2017 | 364781 | 0.070 |
Why?
|
Cultural Characteristics | 1 | 2007 | 250 | 0.060 |
Why?
|
Mycobacterium bovis | 3 | 1983 | 148 | 0.060 |
Why?
|
Vena Cava, Superior | 1 | 1986 | 197 | 0.060 |
Why?
|
Cyclosporins | 1 | 1985 | 216 | 0.060 |
Why?
|
Biotechnology | 1 | 2007 | 282 | 0.060 |
Why?
|
Spleen | 5 | 1989 | 2298 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2003 | 5510 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 1986 | 2017 | 0.060 |
Why?
|
Patient Selection | 1 | 1997 | 4266 | 0.060 |
Why?
|
Intraoperative Care | 1 | 1989 | 772 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2015 | 2010 | 0.060 |
Why?
|
Preoperative Care | 1 | 2014 | 2257 | 0.060 |
Why?
|
Tobacco Smoke Pollution | 1 | 1990 | 828 | 0.060 |
Why?
|
Risk | 3 | 2017 | 9642 | 0.060 |
Why?
|
Risk Assessment | 3 | 2015 | 24311 | 0.060 |
Why?
|
Female | 25 | 2017 | 396943 | 0.060 |
Why?
|
Prognosis | 8 | 2014 | 30028 | 0.060 |
Why?
|
Japan | 1 | 2008 | 1418 | 0.060 |
Why?
|
Australia | 1 | 2007 | 1264 | 0.050 |
Why?
|
Clinical Trials Data Monitoring Committees | 1 | 2003 | 25 | 0.050 |
Why?
|
Game Theory | 1 | 2003 | 24 | 0.050 |
Why?
|
Cushing Syndrome | 2 | 1996 | 241 | 0.050 |
Why?
|
Intuition | 1 | 2003 | 20 | 0.050 |
Why?
|
Neoplasms, Experimental | 2 | 1986 | 1232 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2014 | 9182 | 0.050 |
Why?
|
Paternalism | 1 | 2002 | 49 | 0.050 |
Why?
|
Human Experimentation | 1 | 2003 | 124 | 0.050 |
Why?
|
Third-Party Consent | 1 | 2002 | 66 | 0.050 |
Why?
|
Legal Guardians | 1 | 2002 | 59 | 0.050 |
Why?
|
Uncertainty | 1 | 2007 | 758 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5532 | 0.050 |
Why?
|
Middle Aged | 18 | 2017 | 223418 | 0.050 |
Why?
|
Preoperative Period | 2 | 2015 | 564 | 0.050 |
Why?
|
Social Values | 1 | 2003 | 225 | 0.050 |
Why?
|
Medical Audit | 1 | 2003 | 454 | 0.050 |
Why?
|
Esophageal Atresia | 1 | 1984 | 225 | 0.050 |
Why?
|
Ethics Committees | 1 | 2001 | 51 | 0.050 |
Why?
|
Students, Medical | 2 | 2012 | 1962 | 0.050 |
Why?
|
Budgets | 1 | 2003 | 232 | 0.050 |
Why?
|
Beverages | 1 | 1986 | 822 | 0.050 |
Why?
|
Aged | 14 | 2017 | 171520 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 5 | 1994 | 9425 | 0.050 |
Why?
|
Prisons | 1 | 2003 | 178 | 0.050 |
Why?
|
Appendix | 4 | 1971 | 109 | 0.050 |
Why?
|
Transplantation, Heterologous | 2 | 1986 | 2393 | 0.040 |
Why?
|
Adult | 14 | 2015 | 223542 | 0.040 |
Why?
|
Europe | 1 | 2007 | 3439 | 0.040 |
Why?
|
Isoniazid | 5 | 1982 | 288 | 0.040 |
Why?
|
Ophthalmology | 1 | 2006 | 560 | 0.040 |
Why?
|
Empyema, Tuberculous | 1 | 1979 | 2 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2483 | 0.040 |
Why?
|
Immunotherapy | 5 | 1987 | 4728 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2011 | 7451 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2005 | 2932 | 0.040 |
Why?
|
Pleura | 5 | 1981 | 248 | 0.040 |
Why?
|
Mice, Inbred Strains | 4 | 1988 | 1770 | 0.040 |
Why?
|
Kidney | 5 | 1989 | 7064 | 0.040 |
Why?
|
Organizational Policy | 1 | 2001 | 434 | 0.040 |
Why?
|
Research | 4 | 2010 | 1984 | 0.040 |
Why?
|
Waiting Lists | 1 | 2003 | 778 | 0.040 |
Why?
|
Biopsy | 1 | 1990 | 6816 | 0.040 |
Why?
|
Antibody Formation | 4 | 1971 | 1393 | 0.040 |
Why?
|
Educational Measurement | 1 | 2005 | 1256 | 0.040 |
Why?
|
Health Care Costs | 1 | 2011 | 3265 | 0.040 |
Why?
|
Combined Modality Therapy | 5 | 1994 | 8559 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 1990 | 2562 | 0.040 |
Why?
|
Transplantation Immunology | 4 | 1971 | 538 | 0.040 |
Why?
|
Ligation | 1 | 1998 | 447 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2006 | 1081 | 0.040 |
Why?
|
Professional-Patient Relations | 1 | 2002 | 727 | 0.040 |
Why?
|
Histological Techniques | 1 | 1977 | 194 | 0.030 |
Why?
|
Wisconsin | 1 | 2017 | 122 | 0.030 |
Why?
|
Neoplasm Staging | 7 | 1994 | 11249 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 1994 | 10358 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2519 | 0.030 |
Why?
|
Diet | 1 | 1994 | 8098 | 0.030 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1998 | 290 | 0.030 |
Why?
|
Tape Recording | 1 | 2015 | 77 | 0.030 |
Why?
|
Mediastinal Neoplasms | 2 | 1993 | 403 | 0.030 |
Why?
|
Fear | 1 | 2004 | 1494 | 0.030 |
Why?
|
Communication | 1 | 2009 | 3910 | 0.030 |
Why?
|
Debrisoquin | 1 | 1994 | 6 | 0.030 |
Why?
|
Diaphragm | 1 | 1996 | 360 | 0.030 |
Why?
|
Paraneoplastic Syndromes | 1 | 1996 | 155 | 0.030 |
Why?
|
Device Approval | 1 | 1996 | 164 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2012 | 2437 | 0.030 |
Why?
|
Malignant Carcinoid Syndrome | 1 | 1994 | 31 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2009 | 4340 | 0.030 |
Why?
|
Attitude to Health | 1 | 2003 | 2030 | 0.030 |
Why?
|
Lymphoid Tissue | 4 | 1971 | 446 | 0.030 |
Why?
|
Dementia | 1 | 2008 | 2723 | 0.030 |
Why?
|
Carcinoma | 2 | 1976 | 2341 | 0.030 |
Why?
|
Parents | 1 | 2006 | 3596 | 0.030 |
Why?
|
Hemangioma, Cavernous | 1 | 1993 | 107 | 0.030 |
Why?
|
beta Carotene | 1 | 1994 | 523 | 0.030 |
Why?
|
Mental Competency | 1 | 2013 | 179 | 0.020 |
Why?
|
Negotiating | 1 | 2013 | 152 | 0.020 |
Why?
|
Terminally Ill | 1 | 2014 | 240 | 0.020 |
Why?
|
Personal Autonomy | 1 | 2014 | 315 | 0.020 |
Why?
|
Methods | 2 | 1986 | 1067 | 0.020 |
Why?
|
Lung Diseases, Obstructive | 1 | 1972 | 311 | 0.020 |
Why?
|
New York | 1 | 1994 | 882 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 1979 | 2003 | 0.020 |
Why?
|
Transplantation, Homologous | 6 | 1971 | 4834 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 1996 | 959 | 0.020 |
Why?
|
Esthetics | 1 | 2012 | 329 | 0.020 |
Why?
|
Vitamin A | 1 | 1994 | 611 | 0.020 |
Why?
|
Vaccines | 1 | 1979 | 845 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2006 | 3682 | 0.020 |
Why?
|
Managed Care Programs | 1 | 1996 | 941 | 0.020 |
Why?
|
Odds Ratio | 2 | 1994 | 9687 | 0.020 |
Why?
|
Tissue Banks | 3 | 1966 | 184 | 0.020 |
Why?
|
Transposition of Great Vessels | 1 | 1974 | 580 | 0.020 |
Why?
|
Abdomen | 1 | 1996 | 1136 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2001 | 1468 | 0.020 |
Why?
|
Technetium | 1 | 1990 | 326 | 0.020 |
Why?
|
Fibrosarcoma | 2 | 1983 | 313 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 1996 | 685 | 0.020 |
Why?
|
Vitamin E | 1 | 1994 | 873 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 1998 | 1134 | 0.020 |
Why?
|
Aneurysm | 1 | 1972 | 338 | 0.020 |
Why?
|
Radiation Effects | 3 | 1970 | 73 | 0.020 |
Why?
|
Forecasting | 1 | 1998 | 2950 | 0.020 |
Why?
|
Wound Healing | 2 | 1996 | 2819 | 0.020 |
Why?
|
Doxorubicin | 3 | 1987 | 2229 | 0.020 |
Why?
|
Thymus Gland | 2 | 1971 | 1267 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2006 | 5367 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2015 | 65409 | 0.020 |
Why?
|
Rabbits | 5 | 1971 | 4786 | 0.020 |
Why?
|
Heart Atria | 1 | 1974 | 1361 | 0.020 |
Why?
|
Pulmonary Valve | 1 | 1972 | 413 | 0.020 |
Why?
|
Fruit | 1 | 1994 | 1165 | 0.020 |
Why?
|
Vegetables | 1 | 1994 | 1202 | 0.020 |
Why?
|
Lymph Nodes | 4 | 1975 | 3472 | 0.020 |
Why?
|
Ohio | 1 | 1989 | 328 | 0.020 |
Why?
|
Patient Care Team | 1 | 1999 | 2526 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1989 | 2087 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1988 | 359 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 1996 | 1669 | 0.020 |
Why?
|
Streptococcus | 1 | 1988 | 198 | 0.020 |
Why?
|
Models, Educational | 1 | 2010 | 375 | 0.020 |
Why?
|
Skin Transplantation | 5 | 1971 | 1097 | 0.020 |
Why?
|
Pyrrolizidine Alkaloids | 1 | 1986 | 10 | 0.020 |
Why?
|
Tetralogy of Fallot | 1 | 1972 | 628 | 0.020 |
Why?
|
Quality of Life | 1 | 2008 | 13497 | 0.020 |
Why?
|
Cyclophosphamide | 3 | 1987 | 2224 | 0.020 |
Why?
|
Role | 1 | 2006 | 176 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 1990 | 1998 | 0.020 |
Why?
|
Fibroblasts | 1 | 1996 | 4180 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 1988 | 1379 | 0.020 |
Why?
|
Endotoxins | 1 | 1988 | 520 | 0.020 |
Why?
|
Heart-Lung Machine | 1 | 1965 | 44 | 0.020 |
Why?
|
Sex | 2 | 1966 | 53 | 0.020 |
Why?
|
Focus Groups | 1 | 2011 | 1448 | 0.020 |
Why?
|
Health Policy | 1 | 1997 | 2699 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2339 | 0.010 |
Why?
|
Recovery of Function | 1 | 2015 | 2994 | 0.010 |
Why?
|
Follow-Up Studies | 7 | 1987 | 39430 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 1992 | 3637 | 0.010 |
Why?
|
Pregnancy | 1 | 2006 | 30179 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1988 | 1355 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1989 | 2126 | 0.010 |
Why?
|
Cadaver | 2 | 1966 | 1362 | 0.010 |
Why?
|
Sarcoma, Experimental | 2 | 1983 | 117 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8908 | 0.010 |
Why?
|
Insurance, Health | 1 | 1996 | 2513 | 0.010 |
Why?
|
Recurrence | 1 | 1996 | 8510 | 0.010 |
Why?
|
Urea | 1 | 1966 | 447 | 0.010 |
Why?
|
Lymphocytes | 3 | 1972 | 2611 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1972 | 1949 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 1986 | 13708 | 0.010 |
Why?
|
Esophageal Stenosis | 1 | 1984 | 197 | 0.010 |
Why?
|
Time Factors | 4 | 1990 | 40271 | 0.010 |
Why?
|
Injections | 2 | 1977 | 840 | 0.010 |
Why?
|
Lymph | 1 | 1963 | 78 | 0.010 |
Why?
|
Drainage | 2 | 1972 | 1179 | 0.010 |
Why?
|
Animals | 16 | 1989 | 169418 | 0.010 |
Why?
|
Esophageal Fistula | 1 | 1963 | 60 | 0.010 |
Why?
|
Consensus | 1 | 2012 | 3207 | 0.010 |
Why?
|
Skin | 1 | 1996 | 4520 | 0.010 |
Why?
|
Azathioprine | 1 | 1964 | 354 | 0.010 |
Why?
|
Dogs | 3 | 1979 | 3847 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1994 | 10784 | 0.010 |
Why?
|
Survival Rate | 1 | 1996 | 12875 | 0.010 |
Why?
|
Rats | 2 | 1989 | 23839 | 0.010 |
Why?
|
Mice | 8 | 1988 | 82045 | 0.010 |
Why?
|
Ascites | 1 | 1963 | 339 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1987 | 1629 | 0.010 |
Why?
|
Laser Therapy | 1 | 1987 | 1107 | 0.010 |
Why?
|
Clinical Clerkship | 1 | 2006 | 566 | 0.010 |
Why?
|
Purines | 1 | 1964 | 614 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1994 | 12096 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1988 | 6135 | 0.010 |
Why?
|
Carcinoma, Bronchogenic | 1 | 1979 | 87 | 0.010 |
Why?
|
Mesocricetus | 1 | 1979 | 255 | 0.010 |
Why?
|
Family | 1 | 1990 | 3208 | 0.010 |
Why?
|
Fibrosis | 1 | 1986 | 2076 | 0.010 |
Why?
|
Case-Control Studies | 2 | 1994 | 22293 | 0.010 |
Why?
|
Immune Tolerance | 2 | 1966 | 2326 | 0.010 |
Why?
|
Antigens | 1 | 1964 | 1443 | 0.010 |
Why?
|
Internet | 1 | 2010 | 3123 | 0.010 |
Why?
|
Postoperative Period | 1 | 1982 | 1833 | 0.010 |
Why?
|
Smoking | 1 | 1994 | 9099 | 0.010 |
Why?
|
Health Surveys | 1 | 2006 | 4056 | 0.010 |
Why?
|
Random Allocation | 1 | 1981 | 2399 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 1977 | 277 | 0.010 |
Why?
|
Infant | 3 | 2006 | 36497 | 0.010 |
Why?
|
Cricetinae | 1 | 1979 | 2423 | 0.010 |
Why?
|
Retrospective Studies | 3 | 1994 | 81834 | 0.010 |
Why?
|
Lung | 2 | 1992 | 10090 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 3 | 1971 | 491 | 0.010 |
Why?
|
Lung Diseases | 1 | 1984 | 1926 | 0.010 |
Why?
|
Kidney Transplantation | 2 | 1966 | 4285 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1994 | 363 | 0.010 |
Why?
|
Radiography | 1 | 1984 | 6995 | 0.010 |
Why?
|
Angiocardiography | 1 | 1972 | 149 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1966 | 4213 | 0.010 |
Why?
|
Leukopenia | 2 | 1985 | 214 | 0.010 |
Why?
|
Radiation Injuries | 1 | 1979 | 1205 | 0.010 |
Why?
|
Mediastinum | 1 | 1993 | 273 | 0.010 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1974 | 452 | 0.010 |
Why?
|
Brucella abortus | 1 | 1971 | 14 | 0.010 |
Why?
|
Brucella | 1 | 1971 | 10 | 0.010 |
Why?
|
Antibody-Producing Cells | 1 | 1971 | 140 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1977 | 2362 | 0.010 |
Why?
|
Radiation Injuries, Experimental | 1 | 1971 | 89 | 0.010 |
Why?
|
Salmonella | 1 | 1971 | 125 | 0.010 |
Why?
|
Child | 2 | 2006 | 80863 | 0.010 |
Why?
|
Adolescent | 2 | 2006 | 89168 | 0.010 |
Why?
|
Prospective Studies | 3 | 2006 | 54914 | 0.010 |
Why?
|
Administration, Oral | 1 | 1977 | 4041 | 0.000 |
Why?
|
Skin Tests | 1 | 1971 | 639 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1976 | 2930 | 0.000 |
Why?
|
Animals, Newborn | 2 | 1971 | 2696 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 1987 | 11843 | 0.000 |
Why?
|
Antigens, Bacterial | 1 | 1972 | 1150 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1978 | 4931 | 0.000 |
Why?
|
Age Factors | 1 | 1983 | 18478 | 0.000 |
Why?
|
Immunity, Cellular | 1 | 1972 | 1561 | 0.000 |
Why?
|
Liver | 3 | 1979 | 7575 | 0.000 |
Why?
|
Risk Factors | 2 | 1994 | 74915 | 0.000 |
Why?
|
Semustine | 1 | 1985 | 11 | 0.000 |
Why?
|
Etoposide | 1 | 1987 | 640 | 0.000 |
Why?
|
Lymphatic System | 1 | 1966 | 253 | 0.000 |
Why?
|
Kidney Function Tests | 1 | 1966 | 681 | 0.000 |
Why?
|
Child, Preschool | 1 | 2006 | 42623 | 0.000 |
Why?
|
Freeze Drying | 1 | 1983 | 97 | 0.000 |
Why?
|
Vincristine | 1 | 1985 | 1039 | 0.000 |
Why?
|
Intestine, Small | 1 | 1968 | 1218 | 0.000 |
Why?
|
Lymph Node Excision | 1 | 1987 | 1276 | 0.000 |
Why?
|
Intestines | 1 | 1970 | 1912 | 0.000 |
Why?
|
Gallium Radioisotopes | 1 | 1981 | 195 | 0.000 |
Why?
|
False Negative Reactions | 1 | 1981 | 575 | 0.000 |
Why?
|
Myelitis | 1 | 1979 | 49 | 0.000 |
Why?
|
False Positive Reactions | 1 | 1981 | 962 | 0.000 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1983 | 1339 | 0.000 |
Why?
|
Esophagitis | 1 | 1979 | 165 | 0.000 |
Why?
|
Macrophages | 1 | 1972 | 5797 | 0.000 |
Why?
|
Thrombocytopenia | 1 | 1985 | 1183 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1985 | 4861 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1972 | 13026 | 0.000 |
Why?
|
Phenotype | 1 | 1994 | 16712 | 0.000 |
Why?
|
RNA | 1 | 1966 | 2727 | 0.000 |
Why?
|
Pulmonary Fibrosis | 1 | 1979 | 507 | 0.000 |
Why?
|
Tissue Donors | 1 | 1965 | 2377 | 0.000 |
Why?
|
Radiography, Thoracic | 1 | 1981 | 1320 | 0.000 |
Why?
|
Liver Transplantation | 1 | 1965 | 2399 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1993 | 20762 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1979 | 6320 | 0.000 |
Why?
|
Thymectomy | 1 | 1970 | 200 | 0.000 |
Why?
|
Hemagglutination Tests | 1 | 1968 | 76 | 0.000 |
Why?
|
gamma-Globulins | 1 | 1968 | 119 | 0.000 |
Why?
|
Serum Albumin, Bovine | 1 | 1968 | 320 | 0.000 |
Why?
|
Bursa of Fabricius | 1 | 1966 | 4 | 0.000 |
Why?
|
Immunoelectrophoresis | 1 | 1966 | 94 | 0.000 |
Why?
|
Poultry | 1 | 1966 | 80 | 0.000 |
Why?
|
Salmonella typhi | 1 | 1968 | 200 | 0.000 |
Why?
|
Plasma Cells | 1 | 1970 | 598 | 0.000 |
Why?
|
Chickens | 1 | 1968 | 860 | 0.000 |
Why?
|
Digestive System | 1 | 1966 | 244 | 0.000 |
Why?
|
Freezing | 1 | 1966 | 311 | 0.000 |
Why?
|
Sheep | 1 | 1968 | 1451 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1968 | 1604 | 0.000 |
Why?
|
Amyloidosis | 1 | 1970 | 879 | 0.000 |
Why?
|
Erythrocytes | 1 | 1968 | 2422 | 0.000 |
Why?
|
Graft vs Host Disease | 1 | 1970 | 3042 | 0.000 |
Why?
|
Myocardium | 1 | 1966 | 4788 | 0.000 |
Why?
|